Abeona Therapeutics (ABEO)
NASDAQ:ABEO
Holding ABEO?
Track your performance easily

Abeona Therapeutics (ABEO) Financial Statements

1,343 Followers

Abeona Therapeutics Financial Overview

Abeona Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.545; its P/E ratio is -2.51; Abeona Therapeutics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----$ 3.50M
Gross Profit---$ -30.00K$ 3.50M
EBIT$ 8.48M$ -1.97M$ -16.48M$ -11.73M$ -16.55M
EBITDA$ 9.22M$ -1.30M$ -15.76M$ -10.98M$ -15.60M
Net Income Common Stockholders$ 7.41M$ -31.58M$ -16.59M$ -11.84M$ -16.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.71M$ 62.34M$ 52.23M$ 53.75M$ 36.77M
Total Assets$ 134.00M$ 74.83M$ 64.00M$ 66.09M$ 53.55M
Total Debt$ 23.16M$ 27.86M$ 9.98M$ 5.69M$ 5.97M
Net Debt$ -99.54M$ -34.48M$ -42.25M$ -48.06M$ -30.80M
Total Liabilities$ 60.76M$ 83.71M$ 49.18M$ 44.05M$ 39.84M
Stockholders Equity$ 73.24M$ -8.88M$ 14.83M$ 22.04M$ 9.35M
Cash Flow-
Free Cash Flow$ -13.38M$ -15.26M$ -9.27M$ -5.79M$ -10.14M
Operating Cash Flow$ -12.68M$ -14.54M$ -9.23M$ -5.75M$ -10.28M
Investing Cash Flow$ -44.13M$ -7.82M$ 11.53M$ -18.74M$ 5.21M
Financing Cash Flow$ 73.68M$ 25.44M$ 7.47M$ 22.98M$ 6.62M
Currency in USD

Abeona Therapeutics Earnings and Revenue History

Abeona Therapeutics Debt to Assets

Abeona Therapeutics Cash Flow

Abeona Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis